Yu, L., Li, Y., Gris, A
The FDA also said that drugs containing BPC-157 might harbor impurities, and that the peptide lacks complete safety-related information
Clinical studies specifically monitoring glucose metabolism through oral glucose tolerance tests found no significant changes in glucose handling, and fasting insulin levels remained stable throughout treatment periods lasting up to 24 weeks
Ilic, S., Drmic, D., Franjic, S., Kolenc, D., Coric, M., Brcic, L., Klicek, R., Radic, B., Sever, M., Djuzel, V., Filipovic, M., Djakovic, Z., Stambolija, V., Blagaic, A
Semaglutide enables the body to use glucose more efficiently